ArticleCell reports. Medicine2024

Targeting DNMT3A-mediated oxidative phosphorylation to overcome ibrutinib resistance in mantle cell lymphoma.

Nguyet-Minh Hoang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.